Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Glutathione and Epigallocatechin Gallate

Research Papers that Mention the Interaction

Importantly, the polyphenol coating EGCg ) used in this study could be biodegraded by acidic pH and intracellular glutathione , resulting in the release of trapped anticancer drugs.
Nanoscale  •  2016  |  View Paper
In the cells incubated with EGCG , the consumption of alpha-Toc and the formation of the oxidized form of GSH were suppressed.
Journal of nutritional science and vitaminology  •  2002  |  View Paper
Malathion significantly reduced GSH content, but pre-treatment with EGCG significantly recovered GSH content.
Drug research  •  2020  |  View Paper
The cotreatment with SF and EGCG was effective in reducing ROS production, increasing GSH levels, and enhancing the endogenous antioxidant defences through the upregulation of glutathione reductase, NAD(P)H:quinone oxidoreductase-1, and thioredoxin reductase.
Oxidative medicine and cellular longevity  •  2018  |  View Paper
Compared with MC-LR, EGCG significantly increased superoxide dismutase (SOD) and glutathione (GSH) levels and decreased malondialdehyde (MDA) levels.
Chemosphere  •  2017  |  View Paper
EGCG reduced the glutathione levels, which might be responsible for enhanced ROS generation causing oxidative stress in endometrial cancer cells.
The Journal of nutritional biochemistry  •  2013  |  View Paper
However, EGCG pretreatment significantly increased the activities of GSH , antioxidant enzymes and membrane bound ATPases.
Pharmacological reports : PR  •  2010  |  View Paper
In G6PD-deficient cells, GSH was reduced by 43.3% (EGC at 0.05 mg/ml) and 33.3% ( EGCG at 0.5 mg/ml), compared with pre-challenged levels.
International journal of molecular medicine  •  2006  |  View Paper
EGCG (10 μM) treatment reduced the ROS and MDA levels, while increased the antioxidant capacity and GSH concentrations in the mature oocytes.
Drug design, development and therapy  •  2021  |  View Paper
EGCG significantly decreased H2O2-reduced cell viability and apoptotic cells with DNA damage, … antioxidant capacity (T-AOC), glutathione peroxidase (GSH-PX), superoxide dismutase (SOD), glutathione (GSH), and glutathione disulfide (GSSG), and suppressed the increase in intracellular reactive … oxide synthesis (NOS), malondialdehyde (MDA), lipid peroxide (LPO), and protein carbonyl (Carbonyl).
Oxidative medicine and cellular longevity  •  2020  |  View Paper
Show More